These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23011173)

  • 1. Clinical impact of temporary therapy interruptions on anticoagulation control in patients treated with warfarin.
    Boros ML; Rybarczyk AM; Gallegos PJ; Zimmerman JP
    Am J Ther; 2013; 20(3):267-74. PubMed ID: 23011173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of warfarin dosing requirements after bariatric surgery in patients requiring long-term warfarin therapy.
    Irwin AN; McCool KH; Delate T; Witt DM
    Pharmacotherapy; 2013 Nov; 33(11):1175-83. PubMed ID: 23744816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
    Ripley TL; Harrison D; Germany RE; Adamson PB
    Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
    J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of thromboembolism with short-term interruption of warfarin therapy.
    Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
    Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial.
    Verret L; Couturier J; Rozon A; Saudrais-Janecek S; St-Onge A; Nguyen A; Basmadjian A; Tremblay S; Brouillette D; de Denus S
    Pharmacotherapy; 2012 Oct; 32(10):871-9. PubMed ID: 23033226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study.
    Menzin J; Boulanger L; Hauch O; Friedman M; Marple CB; Wygant G; Hurley JS; Pezzella S; Kaatz S
    Ann Pharmacother; 2005 Mar; 39(3):446-51. PubMed ID: 15701783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.
    Van Spall HG; Wallentin L; Yusuf S; Eikelboom JW; Nieuwlaat R; Yang S; Kabali C; Reilly PA; Ezekowitz MD; Connolly SJ
    Circulation; 2012 Nov; 126(19):2309-16. PubMed ID: 23027801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
    Garwood CL; Dumo P; Baringhaus SN; Laban KM
    Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of subtherapeutic anticoagulation in the United States.
    Rose AJ; Ozonoff A; Grant RW; Henault LE; Hylek EM
    Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):591-7. PubMed ID: 20031897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical application of the 10-mg warfarin initiation nomogram.
    Wells PS; Le Gal G; Tierney S; Carrier M
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):403-8. PubMed ID: 19521238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.
    Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD
    Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
    Meijer K; Kim YK; Carter D; Schulman S
    Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients.
    Jones KL; Barnett C; Gauthier M; Boster B; Espirito JL; Michaud LB
    J Oncol Pharm Pract; 2012 Mar; 18(1):122-7. PubMed ID: 21364079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy.
    Shields RC; McBane RD; Kuiper JD; Li H; Heit JA
    Mayo Clin Proc; 2001 Mar; 76(3):260-6. PubMed ID: 11243272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periprocedural anticoagulation management of patients with venous thromboembolism.
    McBane RD; Wysokinski WE; Daniels PR; Litin SC; Slusser J; Hodge DO; Dowling NF; Heit JA
    Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):442-8. PubMed ID: 20139361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preemptive dose reduction of warfarin in patients initiating metronidazole.
    Holt RK; Anderson EA; Cantrell MA; Shaw RF; Egge JA
    Drug Metabol Drug Interact; 2010; 25(1-4):35-9. PubMed ID: 21417792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.